期刊文献+

间断和“持续”血液灌流治疗急性百草枯中毒的疗效观察 被引量:6

The Clinical Effect of Intermittent and Continuous Hemoperfusion in the Treatment of Acute Paraquat Poisoning
在线阅读 下载PDF
导出
摘要 目的:观察间断和"持续"血液灌流对急性百草枯中毒患者的临床疗效。方法:回顾性研究本院急性百草枯中毒患者59例,所有患者均采用内科常规综合治疗,分为A组26例采用间断血液灌流,B组33例采用"持续"血液灌流,根据患者预后又分为死亡组和存活组。结果:A、B两组患者性别、年龄、服药剂量、服药后至入院治疗时间比较差异无统计学意义(P>0.05);A、B两组患者治疗疗效比较差异无统计学意义(P>0.05),B组死亡患者存活时间长于A组(P<0.05);与存活组相比,死亡组服药剂量明显增高。结论:间断和"持续"血液灌流对于百草枯中毒患者疗效相同,"持续"血液灌流能明显延长中毒死亡患者的存活时间,中毒患者死亡因素主要与患者服用百草枯剂量有关。 Objective: To assess the clinical effects of intermittent and continuous hemoperfusion on acute paraquat poisoning. Method: 59 patients with acute paraquat poisoning were randomly divided into two groups, A group composed of 26 patients were treated with intermittent hemoperfusion and continuous hemoperfusion was administered in B group composed of 33 patients. All patients were treated with conventional medication, then, According to the prognosis of the patients was divided into death group and survival group. Result: There were no significant difference in Gender, age, the toxic dose, and after the poisoning to hospitalization time between the two groups ( P〉0.05 ) . Therapeutic effect of the A and B group had no difference ( P〉0.05 ) . The survival time of death patients in the B group was longer than that of death patients in the A group ( P〈0.05 ) . Compared with the survival group, the toxic dose was higher significantly in death group. Conclusion: There is no difference in the clinical efficacy between intermittent and continuous hemoperfusion on acute paraquat poisoning, continuous hemoperfusion can prolong the survival time of death obviously, the main causes of death is related to the toxic dose.
出处 《中国医学创新》 CAS 2014年第17期30-33,共4页 Medical Innovation of China
关键词 血液灌流 百草枯 病死率 Paraquat poisoning Hemoperfusion Mortality
  • 相关文献

参考文献10

二级参考文献117

共引文献179

同被引文献85

  • 1夏艳,李林美,潘李莉,熊杰.急性有机磷中毒患者进食时间与病情反跳的关系[J].中华护理杂志,2004,39(12):899-900. 被引量:54
  • 2Ghannoum M, Bouchard J, Nolin TD, et al. Hemoperfusion for the treatment of poisoning: technology, determinants of poison clearance, and application in clinical practice [J].Semin Dial,2014, 27(4):350-361.
  • 3Wu WP, Lai MN, Lin CH, et al. Addition of immunosuppressive treatment to hemoperfusion is associated with improved survival after paraquat poisoning: a nationwide study[J]. PLoS ONE,2014,9 ( 1 ):e87568.
  • 4Roberts DM, Buckley NA. Pharmacokinetic considerations in clinical toxicology: clinical applications[J]. Clin Pharmacokinet,2007,46 ( 11 ):897-939.
  • 5Hawksworth GM, Bennett PN, Davies DS. Kinetics of paraquat elimination in the dog [J].Toxicol Appl Pharmacol,1981,57(2):139- 145.
  • 6Hong SY, Yang JO, Lee E Y, et al. Effect of haemoperfusion on plasma paraquat concentration in vitro and in vivo [J].Toxicol Ind Health,2003,19( 1 ): 17-23.
  • 7Hampson EC, Effeney DJ, Pond SM. Efficacy of single or repeated hemoperfusion in a canine model of paraquat poisoning [J].J Pharmaeol Exp Ther,1990,254(2):732-740.
  • 8Winchester JF, Harbord NB. Intoxications amenable to extracorporeal removal[J].Adv Chronic Kidney Dis,2011,18 (3): 167 - 171.
  • 9Mardini J, Lavergne V, Roberts D, et al. Case reports of extracorpo- real treatments in poisoning: historical trends[J].Semin Dial,2014,27 (4):402-406.
  • 10Bismuth C, Gamier R, Dally S, et al. Prognosis and treatment ofparaquat poisoning: a review of 28 cases[J]. J Toxicol Clin Toxicol, 1982,19(5):461-474.

引证文献6

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部